» Articles » PMID: 35958554

HTLV-1 Intragenic Viral Enhancer Influences Immortalization Phenotype , but is Dispensable for Persistence and Disease Development in Animal Models

Overview
Journal Front Immunol
Date 2022 Aug 12
PMID 35958554
Authors
Affiliations
Soon will be listed here.
Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is the causative infectious agent of adult T-cell leukemia/lymphoma (ATL) and chronic neurological disease. The disparity between silenced sense transcription versus constitutively active antisense (Hbz) transcription from the integrated provirus is not fully understood. The presence of an internal viral enhancer has recently been discovered in the Tax gene near the 3' long terminal repeat (LTR) of HTLV-1. , this enhancer has been shown to bind SRF and ELK-1 host transcription factors, maintain chromatin openness and viral gene transcription, and induce aberrant host gene transcription near viral integration sites. However, the function of the viral enhancer in the context of early HTLV-1 infection events remains unknown. In this study, we generated a mutant Enhancer virus (mEnhancer) and evaluated its effects on HTLV-1-mediated immortalization, establishment of persistent infection with an rabbit model, and disease development in a humanized immune system (HIS) mouse model. The mEnhancer virus was able to establish persistent infection in rabbits, and there were no significant differences in proviral load or HTLV-1-specific antibody responses over a 25-week study. However, rabbits infected with the mEnhancer virus had significantly decreased sense and antisense viral gene expression at 12-weeks post-infection. HIS mice infected with wt or mEnhancer virus showed similar disease progression, proviral load, and viral gene expression. While mEnhancer virus was able to sufficiently immortalize primary T-lymphocytes in cell culture, the immortalized cells had an altered phenotype (CD8 T-cells), decreased proviral load, decreased sense and anti-sense gene expression, and altered cell cycle progression compared to HTLV-1.wt immortalized cells (CD4 T-cells). These results suggest that the HTLV-1 enhancer element alone does not determine persistence or disease development but plays a pivotal role in regulating viral gene expression.

Citing Articles

HTLV-1 infected T cells cause bone loss via small extracellular vesicles.

Pokhrel N, Panfil A, Habib H, Seeniraj S, Joseph A, Rauch D J Extracell Vesicles. 2024; 13(10):e12516.

PMID: 39385703 PMC: 11464911. DOI: 10.1002/jev2.12516.


Enhancers in T Cell development and malignant lesions.

Zhang T, Zou L Cell Death Discov. 2024; 10(1):406.

PMID: 39284807 PMC: 11405840. DOI: 10.1038/s41420-024-02160-7.


An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits.

Tu J, King E, Maksimova V, Smith S, Macias R, Cheng X J Virol. 2024; 98(2):e0162323.

PMID: 38193692 PMC: 10883802. DOI: 10.1128/jvi.01623-23.


The Pleiotropic Effects of YBX1 on HTLV-1 Transcription.

Smith S, Seth J, Midkiff A, Stahl R, Syu Y, Shkriabai N Int J Mol Sci. 2023; 24(17).

PMID: 37685922 PMC: 10487795. DOI: 10.3390/ijms241713119.


Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia.

Nakajima S, Okuma K Int J Mol Sci. 2023; 24(14).

PMID: 37511495 PMC: 10380921. DOI: 10.3390/ijms241411737.


References
1.
Miyazaki M, Yasunaga J, Taniguchi Y, Tamiya S, Nakahata T, Matsuoka M . Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis. J Virol. 2007; 81(11):5714-23. PMC: 1900290. DOI: 10.1128/JVI.02511-06. View

2.
Winter H, Dayaram T, Marriott S . Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1. J Virol. 2007; 81(23):13075-81. PMC: 2169132. DOI: 10.1128/JVI.00968-07. View

3.
Newbound G, Andrews J, ORourke J, Brady J, Lairmore M . Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes. J Virol. 1996; 70(4):2101-6. PMC: 190046. DOI: 10.1128/JVI.70.4.2101-2106.1996. View

4.
Poiesz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R . Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980; 77(12):7415-9. PMC: 350514. DOI: 10.1073/pnas.77.12.7415. View

5.
Mahgoub M, Yasunaga J, Iwami S, Nakaoka S, Koizumi Y, Shimura K . Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells. Proc Natl Acad Sci U S A. 2018; 115(6):E1269-E1278. PMC: 5819419. DOI: 10.1073/pnas.1715724115. View